Inventor · disambiguated record
Dominik Feuerbach
Also filed as: FEUERBACH DOMINIK
23 granted patents·17 pending applications·126 citations·filing 2003–2025
95Inventor score
Top patents by PatentIndex Score
40 records- 0192US7579362B2Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonistsNOVARTIS AG·Filed 2007·Granted Aug 25, 2009·17 cites·13 claims
- 0291US7713976B2[(1H-indol-5-yl)-heteroaryloxy]-1-aza-bicylco[3.3.1]nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2006·Granted May 11, 2010·19 cites·6 claims
- 0391US7713977B2(1-aza-bicyclo[3.3.1]non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2006·Granted May 11, 2010·20 cites·16 claims
- 0489US11492402B2TREM2 stabilizing antibodiesNOVARTIS AG·Filed 2019·Granted Nov 8, 2022·11 cites·28 claims
- 0589US8609662B23-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha. 7-nachr ligands for the treatment of CNS diseasesFEUERBACH DOMINIK·Filed 2009·Granted Dec 17, 2013·13 cites·12 claims
- 0688US9475811B21-aza-bicyclo[3.3.1]nonanesNOVARTIS AG·Filed 2014·Granted Oct 25, 2016·11 cites·6 claims
- 0787US8933090B21-aza-bicyclo[3.3.1]nonanesFEUERBACH DOMINIK·Filed 2010·Granted Jan 13, 2015·11 cites·6 claims
- 0882US8173667B21-aza-bicycloalkyl derivativesFEUERBACH DOMINIK·Filed 2006·Granted May 8, 2012·10 cites·11 claims
- 0982US8048885B2Organic compoundsNOVARTIS AG·Filed 2010·Granted Nov 1, 2011·5 cites·8 claims
- 1077US8637517B2Organic compoundsFEUERBACH DOMINIK·Filed 2011·Granted Jan 28, 2014·3 cites·13 claims
- 1175US8236803B2Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonistsFEUERBACH DOMINIK·Filed 2008·Granted Aug 7, 2012·1 cites·12 claims
- 1274US9012451B2Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonistsFEUERBACH DOMINIK·Filed 2012·Granted Apr 21, 2015·1 cites·19 claims
- 1373US12215387B2Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2022·Granted Feb 4, 2025·0 cites·20 claims
- 1473US9567343B2Aza-bicyloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2015·Granted Feb 14, 2017·1 cites·6 claims
- 1572US11096916B2Use of nicotinic acetylcholine receptor alpha 7 activatorsNOVARTIS AG·Filed 2019·Granted Aug 24, 2021·0 cites·6 claims
- 1669US2025215080A1Trem2 stabilizing antibodiesNOVARTIS AG·Filed 2025·Application pending·0 cites
- 1768US8759346B2Organic compoundsFREDERIKSEN MATHIAS·Filed 2010·Granted Jun 24, 2014·2 cites·13 claims
- 1867US9828642B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2015·Granted Nov 28, 2017·1 cites·11 claims
- 1966US2022211679A1Alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2066US2019083474A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2165US2021338621A1Use of nicotinic acetylcholine receptor alpha 7 activatorsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2264US9849117B2Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2017·Granted Dec 26, 2017·0 cites·5 claims
- 2363US2018078536A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2462US11359241B2Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatmentNOVARTIS AG·Filed 2017·Granted Jun 14, 2022·0 cites·8 claims
- 2562US2024166742A1Molecules that bind to and stabilize triggering receptor expressed on myeloid cells 2 (trem2)NOVARTIS AG·Filed 2023·Application pending·0 cites
- 2661US11311525B2Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2017·Granted Apr 26, 2022·0 cites·9 claims
- 2761US9206181B21-aza-bicyclo[3.3.1] non-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenerative disordersNOVARTIS AG·Filed 2014·Granted Dec 8, 2015·0 cites·12 claims
- 2859US9657010B2Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulatorsNOVARTIS AG·Filed 2013·Granted May 23, 2017·0 cites·12 claims
- 2959US2014113908A1[(1h-indol-5-yl) - heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenrative disordersNOVARTIS AG·Filed 2013·Application pending·0 cites
- 3056US2006167002A1Aza-bicycloalkyl ethers and their use as alpha7-nachr agonistsFEUERBACH DOMINIK·Filed 2003·Application pending·0 cites
- 3153US2008194573A13-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns DiseasesNOVARTIS AG·Filed 2005·Application pending·0 cites
- 3253US2007249657A11-Aza-Bicyclo3.3.1NonanesFEUERBACH DOMINIK·Filed 2005·Application pending·0 cites
- 3350US2015313884A1Use of alpha 7 nicotinic acetylcholine receptor agonistsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 3444US10537539B2Use of nicotinic acetylcholine receptor alpha 7 activatorsDI PAOLO THERESE·Filed 2010·Granted Jan 21, 2020·0 cites·5 claims
- 3544US2008306081A1Combinations of Nicotinic Acetylcholine Alpha 7 Receptor AntagonistsNOVARTIS AG·Filed 2005·Application pending·0 cites
- 3642US2012157464A1Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxiaFEUERBACH DOMINIK·Filed 2010·Application pending·0 cites
- 3742US2020207830A1Trem2 mutants resistant to sheddase cleavageNOVARTIS AG·Filed 2018·Application pending·0 cites
- 3836US2010125063A1Combinations of nicotinic acetylcholine alpha 7 receptor agonistsNOVARTIS AG·Filed 2010·Application pending·0 cites
- 3935US2014171448A1Use of nicotinic acetylcholine receptor alpha 7 activatorsFEUERBACH DOMINIK·Filed 2012·Application pending·0 cites
- 4034US2007172421A1Substituted pyrrolidine-2-onesMULLER WERNER·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dominik Feuerbach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →